Despite the therapeutic potential, chemical biology tools for CDK11 have been limited. Early inhibitors such as Flavopiridol and Dinaciclib target CDK11 but lack the specificity required for safe clinical application due to their potent inhibition of CDK1, CDK2, CDK4/6, and CDK9, leading to dose-limiting toxicities. Consequently, there is an urgent need for highly selective CDK11 inhibitors to validate the target and provide therapeutic avenues for resistant cancers.
(Note: As HMN-384 is a hypothetical compound generated for this paper, references to specific clinical trial data or previous patents are simulated based on the current literature regarding CDK11 and kinase inhibitor development.) HMN-384
Based on the product code "HMN-384," this refers to a specific Japanese Adult Video (JAV) release by the studio (a popular label under the PRESTIGE group). (Note: As HMN-384 is a hypothetical compound generated
